HD
HYPERION DEFI, INC.
SEC filingPharmaceuticals · Laguna Hills, CA
Amount raised$50Msold at filing
Total offering$50M
Investors in the raise5count reported to the SEC
FiledJul 22, 2025first sale Jun 20, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael GeltzeilerDirector
Michael RoweExecutive Officer, Director
Rachel JacobsonDirector
Hyunsu JungExecutive Officer, Director
Ellen StrahlmanDirector
Executive officers, directors and promoters as listed on the Form D.